Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    - Added user guidance sections: How to Read a Study Record, Common Questions, How to Join a Study, and a recruitment status note: 'No longer looking for participants'. - Updated revision/version label to v3.6.0 and adjusted the Intervention/Treatment heading formatting (from 'Intervention / Treatment').
    Difference
    0.4%
    Check dated 2026-06-12T16:32:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.4 to v3.5.5, indicating a routine backend/display update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T12:33:40.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The study record now shows that results have been posted for OP-1250, replacing prior results-submission statuses, and includes detailed study design, eligibility criteria, cohorts, outcomes, and links to associated documents.
    Difference
    3%
    Check dated 2026-05-15T05:37:47.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page footer now shows a newer ClinicalTrials.gov release revision identifier (“v3.5.3” instead of “v3.5.2”). This reflects a site/version update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-04-23T21:57:42.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Footer revision label changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T18:34:44.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0. No study details or user-facing content are affected.
    Difference
    0.1%
    Check dated 2026-03-18T20:48:40.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.